Adam Gehring received his Ph.D. at Case Western Reserve University in Cleveland, Ohio. His training included a Postdoctoral Fellowship in the Institute of Hepatology at University College London and a position of Senior Research Fellow, and subsequently Assistant Principal Investigator, at the Singapore Institute for Clinical Sciences. Dr. Gehring moved to Saint Louis University as an Assistant Professor in the Molecular Microbiology and Immunology department in March 2013 before joining the Toronto Centre for Liver Disease as Biology Lead in February 2016.
Adam J Gehring, PhD
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Keywords: hepatitis B, immunology, immunotherapy, monocyte, liver, T cells
My lab works closely with our clinical collaborators to obtain minimally invasive, fine-needle aspiration biopsies to investigate mechanisms of pathogenesis using state-of-the-art single cell technologies. My lab also performs immunological monitoring for new HBV drugs during Phase II clinical trials. Combined, these two research arms integrate translational and clinical research studies to drive our investigations into human liver pathogenesis.